In addition, using both in vivo and in vitro studies, we demonstrated for the first time the relationship between insulin pathway mediators and enhanced fatty acid carriers in human placenta, which could be one of the mechanisms involved in fetal fat accretion in GDM. This evidence concerns the gene INS and gestational diabetes.